2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Pertussis Immunisation: new trials by email Literature Review of Pertussis Immunisation trials Research Report on Pertussis Immunisation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants Pneumococcal Conjugate Vaccine formulation 1, Pneumococcal Conjugate Vaccine formulation 2, Pneumococcal Conjugate Vaccine formulation 3 - Pneumococcal Immunisation, Diphtheria Immunisation | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 852 | 2020-05-22 | 2025-09-08 |
| Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults BPZE1, Placebo - Pertussis, Pertussis Immunisation | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 50 | 2018-10-23 | 2024-09-19 |
Whooping Cough (1)
Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bordetella Infections (1) · Gram-Negative Bacterial Infections (1) · Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
13-valent pneumococcal vaccine (1) · CRM197 (non-toxic variant of diphtheria toxin) (1) · Chickenpox Vaccine (1) · Engerix-B (1) · Hepatitis B Vaccines (1) · Herpes Zoster Vaccine (1) · Measles-Mumps-Rubella Vaccine (1) · RotaTeq (1) · Rotavirus Vaccines (1) · Tetanus Toxoid (1) · pentacel (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Sanofi Pasteur, a Sanofi Company (1)
United States (2) · Canada (1) · Honduras (1) · Puerto Rico (1)